Clinical Trials in Los Angeles

Showing 821-840 of 8,055 trials

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

NCT06926920

The goal of this clinical study is to learn more about the study drug sacituzumab govitecan-hziy (SG) given at an alternative dose and schedule, in participants with triple-negative breast cancer (TNBC). The primary objectives of this study are to assess the safety and tolerability of SG given at alternate dose and schedule, to assess the effect on objective response rate (ORR) and progression-free survival (PFS).

Triple Negative Breast Cancer

Gilead Sciences100 participantsStarted Apr 2025

Los Angeles, California, United States • Atlanta, Georgia, United States • Westwood, Kansas, United States +13 more locations

COMPLETEDPHASE2/PHASE3< 1 mile

A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

NCT05721573

A Phase II/III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Determine the Efficacy and Safety of ABC008 in the Treatment of Subjects with Inclusion Body Myositis

Inclusion Body Myositis

Abcuro, Inc.272 participantsStarted Feb 2023

Phoenix, Arizona, United States • Irvine, California, United States • Los Angeles, California, United States +42 more locations

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

Find Trials by Condition in Los Angeles

A Weight Loss Study Evaluating Subcutaneous Treatment With AZD9550 and AZD6234 in Combination Against Placebo or Each of the Drugs Alone

Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD

Study to Compare Efficacy, Safety, and Immunogenicity of LUBT010 (Proposed Ranibizumab Biosimilar) and Lucentis® in Patients With Neovascular AMD

Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma

Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1)

Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms

Exosome-derived Extrahepatic Metastasis Detection By Liquid Biopsy In Colorectal Cancer Liver Metastases

Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

Safety and Efficacy of IMM01-STEM Against Placebo on Muscle Performance in Seniors With Obesity and Muscle Weakness

A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis

R-3750 in Patients With Mild to Moderate Ulcerative Colitis

Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)

Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation

A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma

A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer